NCT00899210已完成不适用
Study of Diagnostic Tests Studying Kinetic Variation of Serum Matrix Metalloproteases After Surgical Treatment and/or Destruction by Radiofrequency in Patients With Hepatic Metastases From Colorectal Cancer
University Hospital, Grenoble0 个研究点目标入组 75 人开始时间: 2003年9月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 75
- 主要终点
- Kinetics of postoperative changes of serum matrix metalloproteinases (MMP) and their inhibitors (TIMP)
研究概览
简要总结
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment.
PURPOSE: This research trial is studying matrix metalloproteinases after surgery or radiofrequency ablation in patients with liver metastases from colorectal cancer.
详细描述
OBJECTIVES:
Primary
- Describe the kinetics of postoperative changes of serum matrix metalloproteinases (MMP) (MMP-1, MMP-2, MMP-7, MMP-9) and their inhibitors (TIMP) (TIMP-1, TIMP-2) as a function of surgical technique.
Secondary
- Determine the predictive value of postoperative risk of recurrence.
- Correlate the risk of recurrence with surgical technique.
- Determine whether elevated serum levels of MMP are a better marker than the carcinoembryonic antigen of hepatic or extrahepatic recurrence.
- Determine whether the postoperative serum of HGF/SF is correlated to changes in plasma levels of MMPs.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Kinetics of postoperative changes of serum matrix metalloproteinases (MMP) and their inhibitors (TIMP)
次要结局
- Predictive value of postoperative risk of recurrence
- Correlation of risk of recurrence with surgical technique
- Elevated serum levels of MMP vs carcinoembryonic antigen as a marker of hepatic or extrahepatic recurrence
- Correlation of postoperative serum HGF/SF with plasma levels in MMPs
研究者
相似试验
已完成
不适用
Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic MelanomaKidney CancerMelanoma (Skin)NCT00617799University of Nebraska15
已完成
不适用
Studying Biomarkers in Samples From Patients With RhabdomyosarcomaSarcomaNCT01433237Children's Oncology Group40
已完成
不适用
Trastuzumab in Treating Women With Metastatic Breast CancerBreast CancerNCT00896376Centre Antoine Lacassagne49
已完成
不适用
Resistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or RemissionLeukemiaNCT00899899Children's Oncology Group135
Unknown
不适用
Isotretinoin in Treating Young Patients With High-Risk NeuroblastomaNeuroblastomaNCT00939965Children's Cancer and Leukaemia Group75